Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain

Selective serotonin reuptake inhibitors (SSRI) are common first-line treatments for major depression. However, a significant number of depressed patients do not respond adequately to these pharmacological treatments. In the present preclinical study, we demonstrate that organic cation transporter 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Orrico-Sanchez, Alejandro, Guiard, Bruno P., Manta, Stella, Callebert, Jacques, Launay, Jean-Marie, Louis, Franck, Paccard, Antoine, Gruszczynski, Carole, Betancur, Catalina, Vialou, Vincent, Gautron, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542329/
https://www.ncbi.nlm.nih.gov/pubmed/37775532
http://dx.doi.org/10.1038/s41398-023-02596-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542329/
https://www.ncbi.nlm.nih.gov/pubmed/37775532
http://dx.doi.org/10.1038/s41398-023-02596-y

Ejemplares similares